Amyris Inc (NASDAQ: AMRS) Investor Securities Class Action Lawsuit 04/03/2019

If you purchased a significant amount of shares of Amyris Inc (NASDAQ: AMRS) between March 15, 2018, and March 19, 2019, and / or if you purchased any NASDAQ: AMRS shares prior to March 2018 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: June 3, 2019. NASDAQ: AMRS investors should contact the Shareholders Foundation, Inc.

To have your information reviewed for options and to recieve notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Company Name(s): 
Amyris
Case Name: 
Amyris Shareholder Class Action Lawsuit 04/03/2019
Case Status: 
Lawsuit Filed
Affected Securities
NASDAQ: AMRS
Lawsuit Overview
Type of Lawsuit: 
Shareholder Class Action
Date Filed: 
04/03/2019
Class Period Begin: 
03/15/2018
Class Period End: 
03/19/2019
Court of Filing: 
U.S. District Court for the Northern District of California
Deadline To File for Lead: 
06/03/2019
Summary: 

An investor in shares of Amyris Inc (NASDAQ: AMRS) filed a lawsuit in the U.S. District Court for the Northern District of California over alleged violations of Federal Securities Laws by Amyris Inc in connection with certain allegedly false and misleading statements made between March 15, 2018, and March 19, 2019.

Emeryville, CA based Amyris, Inc., an integrated renewable products company, delivers alternatives to petroleum, plant, and animal-based products across a range of consumer and industry segments worldwide. Amyris Inc reported that its annual Total Revenue rose from $67.19 million in 2016 to $143.44 million in 2017 and that its Net Loss declined from $97.33 million in 2016 to $72.32 million in 2017.
On March 19, 2019, Amyris Inc (NASDAQ: AMRS) announced was unable to file its annual report for fiscal year ended December 31, 2018 on time due to “the significant time and resources that were devoted to the accounting for and disclosure of the significant transactions with Koninklijke DSM N.V. that closed in November 2018.” Amyris Inc (NASDAQ: AMRS) also disclosed that it was “in the process of completing its evaluation of internal control over financial reporting.”

Shares of Amyris Inc (NASDAQ: AMRS) declined from $9.29 per share in October 2018 to as low as $1.87 per share on March 26, 2019.

According to the complaint the plaintiff alleges on behalf of purchasers of Amyris Inc (NASDAQ: AMRS) common shares between March 15, 2018, and March 19, 2019, that the defendants violated Federal Securities Laws.

More specifically, the plaintiff claims that between March 15, 2018, and March 19, 2019, the Defendants made false and/or misleading statements and/or failed to disclose that the Company lacked sufficient resources to accurately account for certain transactions, that, as a result, there was a material weakness in the Company’s internal controls over financial reporting, that, as a result, the Company would be unable to timely file its annual report, and that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.